iih glp 1 Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain glp-1 for iih GLP-1 Genetics:

More importantly, the decision reflects something bigger than a single drug

Kodera R, Shikata K, Kataoka HU et al (2011) Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

Inflammation plays a role in issues like aches and pains, but also in cardiovascular and neurological health

Formulated to promote mitochondrial function, this supplement supports both central and peripheral nervous system wellness for better mental clarity and emotional balance

In a Phase 2 obesity trial of retatrutide published in the New England Journal of Medicine in 2023, nausea, diarrhea, vomiting and constipation were cited as the most common adverse events, with higher doses associated with more severe problems